Feng Q - Search Results

1

A pilot study: sequential gemcitabine/cisplatin and icotinib as induction therapy for stage IIB to IIIA non-small-cell lung adenocarcinoma.

Lv C, Ma Y, Feng Q, Fang F, Bai H, Zhao B, Yan S, Wu N, Zheng Q, Li S, Chen J, Wang J, Feng Y, Wang Y, Pei Y, Fang J, Yang Y. Lv C, et al. Among authors: feng y, feng q. World J Surg Oncol. 2013 Apr 26;11:96. doi: 10.1186/1477-7819-11-96. World J Surg Oncol. 2013. PMID: 23621919 Free PMC article.

2

[Epidermal growth factor receptor gene mutations and clinicopathologic correlation in 309 patients with non-small cell lung cancer].

Feng Q, Li XH, Chen Z, He JS, Wang CX, Zhou LX, Xue WC. Feng Q, et al. Zhonghua Bing Li Xue Za Zhi. 2011 Oct;40(10):660-3. Zhonghua Bing Li Xue Za Zhi. 2011. PMID: 22321542 Chinese.

3

[Diagnosis for ALK positive non-small cell lung cancer].

Feng Q, Yang X, Lin D. Feng Q, et al. Zhongguo Fei Ai Za Zhi. 2015 Feb;18(2):61-8. doi: 10.3779/j.issn.1009-3419.2015.02.02. Zhongguo Fei Ai Za Zhi. 2015. PMID: 25676397 Free PMC article. Review. Chinese.

4

A Retrospective Study of Stage I to IIIa Lung Adenocarcinoma After Resection: What Is the Optimal Adjuvant Modality for Patients With an EGFR Mutation?

Lv C, An C, Feng Q, Ma Y, Li S, Wang J, Zhang J, Wang X, Yan S, Fang J, Wang Y, Tan F, Yang Y. Lv C, et al. Among authors: feng q. Clin Lung Cancer. 2015 Nov;16(6):e173-81. doi: 10.1016/j.cllc.2015.04.002. Epub 2015 Apr 20. Clin Lung Cancer. 2015. PMID: 25958850 Free article.

5

A comparison of QuantStudio™ 3D Digital PCR and ARMS-PCR for measuring plasma EGFR T790M mutations of NSCLC patients.

Feng Q, Gai F, Sang Y, Zhang J, Wang P, Wang Y, Liu B, Lin D, Yu Y, Fang J. Feng Q, et al. Cancer Manag Res. 2018 Jan 18;10:115-121. doi: 10.2147/CMAR.S148134. eCollection 2018. Cancer Manag Res. 2018. PMID: 29403309 Free PMC article.

6

Co-occurring genetic alterations and primary EGFR T790M mutations detected by NGS in pre-TKI-treated NSCLCs.

Tang Y, Che N, Yu Y, Gao Y, Shi H, Feng Q, Wei B, Ma L, Gao M, Ma J, Lin D. Tang Y, et al. Among authors: feng q. J Cancer Res Clin Oncol. 2020 Feb;146(2):407-416. doi: 10.1007/s00432-019-03065-0. Epub 2019 Nov 6. J Cancer Res Clin Oncol. 2020. PMID: 31696302

7

Does neoadjuvant targeted therapy provide an opportunity for resectable EGFR-mutant lung cancer: a real-world retrospective study.

Lv C, Ma Y, Feng Q, Lu F, Chi Y, Wu N, Fang J, Yang Y. Lv C, et al. Among authors: feng q. J Thorac Dis. 2020 Oct;12(10):5324-5335. doi: 10.21037/jtd-20-1265. J Thorac Dis. 2020. PMID: 33209366 Free PMC article.

8

Transcriptional regulation of PES1 expression by c-Jun in colon cancer.

Xie W, Feng Q, Su Y, Dong B, Wu J, Meng L, Qu L, Shou C. Xie W, et al. Among authors: feng q. PLoS One. 2012;7(7):e42253. doi: 10.1371/journal.pone.0042253. Epub 2012 Jul 30. PLoS One. 2012. PMID: 22860098 Free PMC article.

9

An integrated classifier improves prognostic accuracy in non-metastatic gastric cancer.

Xing X, Jia S, Leng Y, Wang Q, Li Z, Dong B, Guo T, Cheng X, Du H, Hu Y, Feng Q, Lian S, Luan F, Ma X, Li Z, Ni M, Li Z, Ji J. Xing X, et al. Among authors: feng q. Oncoimmunology. 2020 Aug 30;9(1):1792038. doi: 10.1080/2162402X.2020.1792038. Oncoimmunology. 2020. PMID: 32939321 Free PMC article.

10

Folate-Receptor Positive Circulating Tumor Cell Is a Potential Diagnostic Marker of Prostate Cancer.

Lian S, Yang L, Feng Q, Wang P, Wang Y, Li Z. Lian S, et al. Among authors: feng q. Front Oncol. 2021 Oct 8;11:708214. doi: 10.3389/fonc.2021.708214. eCollection 2021. Front Oncol. 2021. PMID: 34692484 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,799 results

Search Page

Filters